Metabolism overview

Michael, M. Doherty, M. M. Tumoral drug metabolism overview and its implications for cancer therapy J. Qin. Oncol. 2005, 23, 205-229. 

NITROGEN FIXATION AND AGRICULTURE Amino Acid Metabolism Overview Reactions of Amino Groups Synthesis of the Amino Acids... 

See DURG METABOLISM Overview Metabolite Isolation and Identification Isotope Studies. CLINICAL ANALYSIS Inborn Errors of Metabolism... 

The World Wide Web has transformed the way in which we obtain and analyze published information on proteins. What only a few years ago would take days or weeks and require the use of expensive computer workstations can now be achieved in a few minutes or hours using personal computers, both PCs and Macintosh, connected to the internet. The Web contains hundreds of sites of Interest to molecular biologists, many of which are listed in Pedro s BioMolecular Research Tools (http // www.fmi.ch/biology/research tools.html). Many sites provide free access to databases that make it very easy to obtain information on structurally related proteins, the amino acid sequences of homologous proteins, relevant literature references, medical information and metabolic pathways. This development has opened up new opportunities for even non-specialists to view and manipulate a structure of interest or to carry out amino-acid sequence comparisons, and one can now rapidly obtain an overview of a particular area of molecular biology. We shall here describe some Web sites that are of interest from a structural point of view. Updated links to these sites can be found in the Introduction to Protein Structure Web site (http // WWW.ProteinStructure.com/). 

All overview of the glycolytic pathway is presented in Figure 19.1. Most of the details of this pathway (the first metabolic pathway to be elucidated) were worked out in the first half of the 20th century by the German biochemists Otto Warburg, G. Embden, and O. Meyerhof. In fact, the sequence of reactions in Figure 19.1 is often referred to as the Embden-Meyerhof pathway. 

The composition of body fluids remains relatively constant despite the many demands placed on the body each day. On occasion, these demands cannot be met, and electrolytes and fluids must be given in an attempt to restore equilibrium. The solutions used in the management of body fluids discussed in this chapter include blood plasma, plasma protein fractions, protein substrates, energy substrates, plasma proteins, electrolytes, and miscellaneous replacement fluids. Electrolytes are electrically charged particles (ions) that are essential for normal cell function and are involved in various metabolic activities. This chapter discusses the use of electrolytes to replace one or more electrolytes that may be lost by the body. The last section of this chapter gives a brief overview of total parenteral nutrition (TPN). 

The literature in this field is confusing because of a somewhat haphazard method of nomenclature that has arisen historically. This is compounded by some mistakes in structure determination, reported in early papers, and which are occasionally quoted. The first part of this chapter deals with nomenclature and with a brief overview of early work. Subsequent sections deal with the formation and metabolism of di-D-fructose dianhydrides by micro-organisms, and the formation of dihexulose dianhydrides by protonic and thermal activation. In relation to the latter topic, recent conclusions regarding the nature of sucrose caramels are covered. Other sections deal with the effects of di-D-fructose dianhydrides upon the industrial production of sucrose and fructose, and the possible ways in which these compounds might be exploited. An overview of the topic of conformational energies and implications for product distributions is also presented. 

Benzodiazepines do not induce their own metabolism, and thete is no evidence for the development of pharmacokinetic toletance (Gteenblatt and Shader 1986). The behavioral tolerance seen with chronic dosing is explicable entirely on the basis of pharmacodynamic tolerance (as described earlier in the overview of neuropharmacology). 

---